mRNA vaccine to give India flexibility against coronavirus, says scientist
Image Credit: economic times
Dr N Madhusudan Rao, CEO-Atal Incubation Centre at Centre for Cellular and Molecular Biology (CCMB) on Monday said that India has developed mRNA technology against the COVID-19. He said that the mRNA platform has the advantage of flexibility which isn`t with other vaccine platforms. The mRNA technology is a messenger RNA, a copy of DNA sequence, and is a blueprint to make a protein.